Canada markets closed

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.12-0.17 (-0.40%)
At close: 04:00PM EDT
42.12 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.32B
Enterprise Value 2.81B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)609.51
Price/Book (mrq)6.15
Enterprise Value/Revenue 700.20
Enterprise Value/EBITDA -12.69

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 3105.46%
S&P500 52-Week Change 322.36%
52 Week High 349.58
52 Week Low 315.76
50-Day Moving Average 342.80
200-Day Moving Average 331.91

Share Statistics

Avg Vol (3 month) 3798.15k
Avg Vol (10 day) 3540.21k
Shares Outstanding 578.74M
Implied Shares Outstanding 679.83M
Float 864.75M
% Held by Insiders 11.92%
% Held by Institutions 196.05%
Shares Short (Apr 15, 2024) 45.22M
Short Ratio (Apr 15, 2024) 44.77
Short % of Float (Apr 15, 2024) 47.35%
Short % of Shares Outstanding (Apr 15, 2024) 46.70%
Shares Short (prior month Mar 15, 2024) 45.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,547.17%

Management Effectiveness

Return on Assets (ttm)-28.18%
Return on Equity (ttm)-50.16%

Income Statement

Revenue (ttm)4.01M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -221.51M
Net Income Avi to Common (ttm)-214.53M
Diluted EPS (ttm)-3.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)558.56M
Total Cash Per Share (mrq)8.03
Total Debt (mrq)51.73M
Total Debt/Equity (mrq)9.59%
Current Ratio (mrq)13.07
Book Value Per Share (mrq)7.91

Cash Flow Statement

Operating Cash Flow (ttm)-166.31M
Levered Free Cash Flow (ttm)-93.53M